BR0304634A - Compostos de imidazolina, processo para a sua preparação e composições farmacêuticas que os contêm - Google Patents

Compostos de imidazolina, processo para a sua preparação e composições farmacêuticas que os contêm

Info

Publication number
BR0304634A
BR0304634A BR0304634-6A BR0304634A BR0304634A BR 0304634 A BR0304634 A BR 0304634A BR 0304634 A BR0304634 A BR 0304634A BR 0304634 A BR0304634 A BR 0304634A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
sym
imidazoline compounds
Prior art date
Application number
BR0304634-6A
Other languages
English (en)
Inventor
Sylvain Rault
Marina Kopp
Jean-Charles Lancelot
Stephane Lemaitre
Daniel-Henri Caignard
Jean-Guy Bizot-Espiard
Pierre Renard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0304634A publication Critical patent/BR0304634A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSTOS DE IMIDAZOLINA, PROCESSO PARA A SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS QUE OS CONTêM". A invenção refere-se a compostos de fórmula (I) em que <sym> R^ 1^ representa um grupo heteroarila opcionalmente substituído, <sym> R^ 2^ representa um grupo cicloalquila opcionalmente substituído, <sym> R^ 3^ representa um átomo de hidrogênio ou um grupo alquila, e <sym> R^ 4^ e R^ 5^ são como definido na descrição, os enanciómeros, diastereoisómeros e tautómeros dos mesmos, e também sais de adição dos mesmos com um ácido ou base farmaceuticamente aceitável. Medicamentos.
BR0304634-6A 2002-10-23 2003-10-21 Compostos de imidazolina, processo para a sua preparação e composições farmacêuticas que os contêm BR0304634A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0213194A FR2846328B1 (fr) 2002-10-23 2002-10-23 Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
BR0304634A true BR0304634A (pt) 2004-06-01

Family

ID=29763935

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0304634-6A BR0304634A (pt) 2002-10-23 2003-10-21 Compostos de imidazolina, processo para a sua preparação e composições farmacêuticas que os contêm

Country Status (25)

Country Link
US (2) US6875788B2 (pt)
EP (1) EP1413579B1 (pt)
JP (1) JP2004143167A (pt)
KR (1) KR100642844B1 (pt)
CN (1) CN1234694C (pt)
AR (1) AR041688A1 (pt)
AT (1) ATE288432T1 (pt)
AU (1) AU2003257606A1 (pt)
BR (1) BR0304634A (pt)
CA (1) CA2445817A1 (pt)
DE (1) DE60300307T2 (pt)
DK (1) DK1413579T3 (pt)
EA (1) EA006197B1 (pt)
ES (1) ES2236672T3 (pt)
FR (1) FR2846328B1 (pt)
HK (1) HK1063320A1 (pt)
MA (1) MA27013A1 (pt)
MX (1) MXPA03009576A (pt)
NO (1) NO20034722L (pt)
NZ (1) NZ529084A (pt)
PL (1) PL363022A1 (pt)
PT (1) PT1413579E (pt)
SG (2) SG113482A1 (pt)
SI (1) SI1413579T1 (pt)
ZA (1) ZA200308265B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023279554A1 (zh) * 2021-07-08 2023-01-12 中国石油化工股份有限公司 环烷基咪唑啉在用于抑制天然气水合物形成的应用及含有其的组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL31555A (en) * 1968-02-09 1972-10-29 Scherico Ltd Cyclic amidines and the therapeutic use thereof
US3932431A (en) * 1970-06-24 1976-01-13 Schering Corporation Certain 2-[α(2-pyridyl)-benzyl] imidazolines and derivatives thereof
US4081544A (en) * 1975-12-04 1978-03-28 Schering Corporation Certain 2-(alpha(2-pyridyl)-benzyl)imidazolines and derivatives thereof
EP0313288B1 (en) * 1987-10-19 1992-12-30 Beecham Group Plc Imidazole derivatives, process for their preparation and their use as alpha 2-adreno-receptor antagonists
GB8916150D0 (en) * 1989-07-14 1989-08-31 Beecham Group Plc Novel compounds
GB9123857D0 (en) * 1991-11-09 1992-01-02 Smithkline Beecham Plc Novel compounds
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JP3416141B2 (ja) * 1994-02-04 2003-06-16 アイシー・ワン・インコーポレイテッド 奨励クレジットの割当て及び割戻し方法及び装置
CA2180891C (en) * 1995-07-12 2010-01-12 Junichi Rekimoto Notification of updates in a three-dimensional virtual reality space sharing system
US5937391A (en) * 1996-07-11 1999-08-10 Fujitsu Limited Point-service system in online shopping mall
US5926179A (en) * 1996-09-30 1999-07-20 Sony Corporation Three-dimensional virtual reality space display processing apparatus, a three-dimensional virtual reality space display processing method, and an information providing medium
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
US20050203835A1 (en) * 1998-01-30 2005-09-15 Eli Nhaissi Internet billing
GB2351081A (en) * 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
US7037194B2 (en) * 2000-03-23 2006-05-02 Atlantic City Coin & Slot Service Company, Inc. Method and device for playing a game
US6672961B1 (en) * 2000-03-16 2004-01-06 Sony Computer Entertainment America Inc. Computer system and method of displaying images
US7383223B1 (en) * 2000-09-20 2008-06-03 Cashedge, Inc. Method and apparatus for managing multiple accounts
US20030118575A1 (en) * 2001-12-11 2003-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Method for administering BIRB 796 BS
US20050235008A1 (en) * 2002-08-01 2005-10-20 Walt Camping Apparatus and method for collateral recovery
US20050177492A1 (en) * 2002-08-01 2005-08-11 Walt Camping Apparatus and method for asset tracking and recovery
US20050137904A1 (en) * 2003-10-14 2005-06-23 Kathleen Lane System and method for monitoring secured liens
US7882023B2 (en) * 2004-06-23 2011-02-01 Paul Parrish Method and system for managing collateral or property risk in a secured loan or lease portfolio
US7055740B1 (en) * 2004-12-06 2006-06-06 Target Brands, Inc. Stored-value card adapted to be read by an electronic device

Also Published As

Publication number Publication date
PL363022A1 (en) 2004-05-04
EP1413579B1 (fr) 2005-02-02
NZ529084A (en) 2005-04-29
FR2846328A1 (fr) 2004-04-30
EA200301045A2 (ru) 2004-04-29
DE60300307T2 (de) 2006-01-19
US20050143440A1 (en) 2005-06-30
ATE288432T1 (de) 2005-02-15
EP1413579A1 (fr) 2004-04-28
KR20040036590A (ko) 2004-04-30
PT1413579E (pt) 2005-05-31
AR041688A1 (es) 2005-05-26
FR2846328B1 (fr) 2004-12-10
NO20034722D0 (no) 2003-10-22
MA27013A1 (fr) 2004-12-20
AU2003257606A1 (en) 2004-05-13
SG127755A1 (en) 2006-12-29
DE60300307D1 (de) 2005-03-10
US6875788B2 (en) 2005-04-05
SG113482A1 (en) 2005-08-29
EA006197B1 (ru) 2005-10-27
HK1063320A1 (en) 2004-12-24
ZA200308265B (en) 2004-07-09
NO20034722L (no) 2004-04-26
JP2004143167A (ja) 2004-05-20
CN1234694C (zh) 2006-01-04
MXPA03009576A (es) 2004-04-29
CA2445817A1 (fr) 2004-04-23
SI1413579T1 (en) 2005-06-30
EA200301045A3 (ru) 2004-08-26
ES2236672T3 (es) 2005-07-16
CN1496982A (zh) 2004-05-19
US20040087638A1 (en) 2004-05-06
DK1413579T3 (da) 2005-05-09
KR100642844B1 (ko) 2006-11-10

Similar Documents

Publication Publication Date Title
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
BR9911013A (pt) Derivados de pirazol como inibidores da p-38 map quinase
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
BR0310077A (pt) Novos compostos e sua utilização
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
NO20054787D0 (no) Indenderivater som farmasotiske midler
BR0212069A (pt) Agentes antidiabéticos orais
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
SE9903894D0 (sv) Novel compounds
BR0315995A (pt) Composto, uso de um composto composição farmacêutica, métodos para a terapia da dor, de distúrbios gastrointestinais, e da ansiedade em um animal de sangue quente, e, processo para preparar um composto
BRPI0601773A (pt) compostos de fenilpiridilpiperazina, um processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
BRPI0411308A8 (pt) Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0214937A (pt) Processo de preparação de derivados de equinocandina
BR9903282A (pt) Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR0300698A (pt) Compostos derivados de quinazolina, um processo para sua preparação e composições farmacêuticas contendo-os
BR0309668A (pt) Imidazolinilmetil aralquilsulfonamidas
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
BRPI0507511A (pt) composto, uso de um composto, composição farmacêutica,e, processo para preparar um composto
BR0304634A (pt) Compostos de imidazolina, processo para a sua preparação e composições farmacêuticas que os contêm
BR9801448A (pt) Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2042 DE 23/02/2010.